These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12638394)

  • 1. Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction.
    Rajagopalan P; Mazzu A; Xia C; Dawkins R; Sundaresan P
    J Clin Pharmacol; 2003 Mar; 43(3):260-7. PubMed ID: 12638394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
    Katsarov M
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
    [No Abstract]   [Full Text] [Related]  

  • 3. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study.
    Klotz T; Sachse R; Heidrich A; Jockenhövel F; Rohde G; Wensing G; Horstmann R; Engelmann R
    World J Urol; 2001 Feb; 19(1):32-9. PubMed ID: 11289568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of food and alcohol on the pharmacokinetics of vardenafil].
    He ZJ
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):477-9. PubMed ID: 15999499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction.
    Kendirci M; Bivalacqua TJ; Hellstrom WJ
    Expert Opin Pharmacother; 2004 Apr; 5(4):923-32. PubMed ID: 15102574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.
    Thadani U; Smith W; Nash S; Bittar N; Glasser S; Narayan P; Stein RA; Larkin S; Mazzu A; Tota R; Pomerantz K; Sundaresan P
    J Am Coll Cardiol; 2002 Dec; 40(11):2006-12. PubMed ID: 12475462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vardenafil: a review of its use in erectile dysfunction.
    Keating GM; Scott LJ
    Drugs; 2003; 63(23):2673-703. PubMed ID: 14636086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil.
    Pomara G; Morelli G; Pomara S; Taddei S; Ghiadoni L; Dinelli N; Travaglini F; Dicuio M; Mondaini N; Salvetti A; Selli C
    J Androl; 2004; 25(4):625-9. PubMed ID: 15223851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification.
    Donatucci C; Eardley I; Buvat J; Gittelman M; Kell P; Segerson T; Homering M; Montorsi F;
    J Sex Med; 2004 Nov; 1(3):301-9. PubMed ID: 16422960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events.
    Bischoff E
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S34-7. PubMed ID: 15224134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.
    Gupta M; Kovar A; Meibohm B
    J Clin Pharmacol; 2005 Sep; 45(9):987-1003. PubMed ID: 16100293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vardenafil--PDE5 inhibitor number 3.
    Jackson G
    Int J Clin Pract; 2004 Mar; 58(3):229. PubMed ID: 15117087
    [No Abstract]   [Full Text] [Related]  

  • 15. Vardenafil: a new approach to the treatment of erectile dysfunction.
    Hellstrom WJ
    Curr Urol Rep; 2003 Dec; 4(6):479-87. PubMed ID: 14622502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vardenafil.
    Young JM
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1487-96. PubMed ID: 12387708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.
    Goldstein I; Young JM; Fischer J; Bangerter K; Segerson T; Taylor T;
    Diabetes Care; 2003 Mar; 26(3):777-83. PubMed ID: 12610037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
    Gresser U; Gleiter CH
    Eur J Med Res; 2002 Oct; 7(10):435-46. PubMed ID: 12435622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.
    Markou S; Perimenis P; Gyftopoulos K; Athanasopoulos A; Barbalias G
    Int J Impot Res; 2004 Dec; 16(6):470-8. PubMed ID: 15229625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective and safe use of Levitra (Vardenafil) for treatment of erectile dysfunction].
    Mazo EB; Gamidov SI; Ovchinnikov RI
    Urologiia; 2004; (3):58-66. PubMed ID: 15199819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.